Stimulation via the T-cell receptor (TCR) activates p38␣ and p38␤ by phosphorylation of p38 Tyr-323 (p38 Y323 ). Here we characterize knockin mice in which p38␣ and/or ␤ Tyr-323 has been replaced with Phe. We find that p38␣ accounts for twothirds and p38␤ the remainder of TCRinduced p38 activation. T cells from double knockin mice (p38␣␤ Y323F ) had defects in TCR-mediated proliferation and Th1 and Th17 skewing, the former corresponding with an inability to sustain T-bet expression. Introduction of p38␣ Y323F into Gadd45␣-deficient mice, in which the alternative p38 pathway is constitutively active, reversed T-cell hyperproliferation and autoimmunity. Furthermore, p38␣␤ Y323F mice had delayed onset and reduced severity of the inflammatory autoimmune diseases collagen-induced arthritis and experimental autoimmune encephalomyelitis. Thus, T cell-specific alternative activation of p38 is an important pathway in T-cell proliferation, Th skewing, and inflammatory autoimmunity, and may be an attractive tissuespecific target for intervention in these processes. (Blood. 2011;118(12):3280-3289)
Introduction
p38, a member of mitogen activated protein kinase (MAPK) family, is a key signaling intermediate downstream of proinflammatory cytokine receptors and environmental stress. 1 The p38 MAPK family has 4 separately encoded members: ␣, ␤, ␥, and ␦. p38␣, ␤, and ␦ are expressed in T cells, whereas p38␥ is largely restricted to skeletal muscle. 2 p38␣ (the major T-cell isoform) and ␤ are the most highly related, sharing 74% homology at the amino acid level. 3 All p38 isoforms are activated via a series of sequential phosphorylation steps. The most stimulus-proximal kinase is a MAP kinase kinase kinase (MAPKKK), which phosphorylates dual-specificity MAP kinase kinases (MAPKKs). Two MAPKKs, MKK3 and MKK6, then phosphorylate Tyr180 and Thr182 in the p38 activation loop, causing conformational changes that result in better access to substrate and increased catalytic activity. [4] [5] [6] In contrast to the MAPK cascade, which is present in all cells, we have described an alternative signaling pathway downstream of the T-cell receptor (TCR) that leads to p38 activation. Ligation of the TCR results in Lck-dependent activation of ZAP70, which in turn phosphorylates p38␣ and p38␤ on Tyr-323 (p38␦ does not possess a tyrosine at this position). 7 Once phosphorylated, p38 autophosphorylates residue T180 (but not Tyr-182) in the activation loop, and enzymatic activity is increased. 6 It is noteworthy that p38 phosphorylated at only T180 has a different substrate specificity than dual-phosphorylated p38, raising the interesting possibility that the alternative pathway may have arisen to support biologic responses unique to T cells. To understand the biologic significance of the alternative p38 activation pathway in vivo, we created knockin mice in which a Tyr-to-Phe substitution was introduced at p38␣ residue 323 (p38␣ Y323F ). 8 This mutation abolished p38␣ activation via TCR signaling without affecting canonical MAPK cascade-induced activation. Lack of TCR-induced p38␣ activity led to a modest but reproducible delay in the onset of T-cell proliferation and decreased production of inflammatory cytokines, such as IFN-␥ and TNF-␣. p38␣ Y323F CD4 ϩ T cells could be skewed to Th1 cells in vivo, but these effector cells produced less IFN-␥ than wild-type (WT) Th1 cells when stimulated via the TCR. 8 In resting T cells, p38 activity is inhibited by Gadd45␣, genetic disruption of which results in constitutive up-regulation of the T cell alternative p38 activation pathway, with hyperproliferation in response to TCR-mediated signals and spontaneous development of lupus-like autoimmunity. 9 Gadd45␣ binds p38 and inhibits kinase activity induced by Tyr-323 phosphorylation. 10 Interestingly, Gadd45␣ also binds and activates MEKK4, an MAPKKK upstream of MKK3 and MKK6, 11 which explains the paradox that in non-T cells Gadd45␣ is a positive regulator of p38 kinase activity, and its absence results in decreased p38-dependent responses, such as IL-12 and CD40 expression in activated dendritic cells and reduced UV-induced apoptosis of keratinocytes. 12, 13 The autoimmunity seen in Gadd45␣ Ϫ/Ϫ mice was presumed to be secondary to elevated T-cell p38 activity and hyperproliferation, but it was not possible to rule out other, uncharacterized, activities of Gadd45␣ in its pathogenesis.
Whereas impaired production of T-cell cytokines negatively affects immune responses to pathogens, 14, 15 excessive production of proinflammatory cytokines contributes to chronic inflammation and autoimmune diseases. 16 For example, increased levels of TNF-␣ were found in serum of patients with pulmonary obstructive disease and in synovial fluids of rheumatoid arthritis patients. 17, 18 In experimental autoimmune encephalomyelitis (EAE), CD4 ϩ T cells infiltrate the central nervous system before the development of clinical symptoms, secrete IFN-␥ and IL-17, and activate CD11b ϩ microglia to produce TNF-␣. 19, 20 p38 phosphorylation (P-p38) was found to be elevated in spinal cord tissue from rats, both in the peak and recovery phases of EAE, and high levels of P-p38 were detected in T cells in EAE lesions. 21 In rheumatoid arthritis, IL-1 and TNF-␣ are major cytokines in initiating inflammatory and destructive processes in affected joints. 18 Collageninduced arthritis (CIA), a murine model of rheumatoid arthritis, can be substantially inhibited by pharmacologic inhibition of p38␣ and p38␤. 22, 23 Given the data demonstrating roles for p38 in autoimmune and inflammatory processes, we asked whether there was a specific contribution made by T-cell p38 activated via TCR occupancy and the alternative pathway. To completely abrogate this pathway, we created p38␤ Y323F knockin mice, which were crossed to p38␣ Y323F mice to generate p38␣␤ Y323F double knockins. We found that, in the absence of TCR-induced p38␣␤ activity, there is a large reduction in T-cell proliferation, proinflammatory cytokine production, and reduced susceptibility to EAE and CIA, establishing alternatively activated T-cell p38␣/␤ as a major factor in regulating T-cell activation and the development of autoimmunity and inflammatory diseases.
Methods

Mice
Gadd45␣ Ϫ/Ϫ mice 24 were backcrossed onto the C57BL/6 (B6) background for 8 generations, and mice heterozygous for Gadd45␣ were intercrossed to obtain Gadd45␣ Ϫ/Ϫ animals used in these studies. p38␣ Y323F8 and p38␤ Y323F mice were backcrossed onto B6 for at least 6 generations. B10.RIII mice were obtained from The Jackson Laboratory and were crossed with p38␣␤ Y323F mice to generate the p38␣␤ Y323F .H-2 r animals. Mice were maintained in an National Cancer Institute pathogen-free animal facility, and all animal experiments were performed under a National Institutes of Health-approved animal study protocol. To generate p38␤ Y323F mice, BAC-DNA (clone RP23-269F24) containing the mouse p38␤ gene was obtained from BACPAC Resource Center. A SacI digest yielding a 5.1-kb region starting upstream of exon 11 and extending downstream of exon 12 was used to construct a targeting vector consisting of a neo-resistance cassette flanked by 2 loxP sites, into which the Y323F mutation was inserted using the QuickChange PCR mutagenesis system (Stratagene). Introduction of the Y323F mutation deleted a BanII-specific restriction site, which was later used for detection of the p38␤ Y323F mutation. Embryonic stem cells [(129 ϫ C57BL/6)F 1 ] were transfected with the targeting vector and injected into C57BL/6 blastocysts. For genotyping, polymerase chain reaction was used to amplify part of p38␤ exon 11 (primers 5Ј ACA TACATCCAGTCTCTGCCTCCC 3Ј and 5Ј TGCTCTCTTTCCCATCCT-CACG 3Ј) yielding a 375-bp product that was digested with BanII.
Reagents
Antibodies against p38␣, phospho-p38, and phospho-ATF-2 were purchased from Cell Signaling; anti-p38␤, anti-␤-actin, anti-T-bet and anti-GATA-3 from Santa Cruz Biotechnology; and CD4, CD8, IL-10, TNF-␣, IL-2, IL-17, IFN-␥, IL-4, and phospho-p38-PE antibodies from BD Biosciences. Anti-rabbit and anti-mouse antibodies conjugated to AlexaFluor680 or JRDye800 were obtained from Invitrogen or Rockland Chemicals, respectively. Phorbol myristate acetate (PMA), ionomycin, dsDNA, histone, and poly-L-lysine were purchased from Sigma-Aldrich.
T-cell isolation, activation, and Th differentiation
Cell suspensions from lymph nodes or spleen were incubated with BioMag goat antimouse IgG and IgM beads (Polysciences) at room temperature for 40 minutes, and B cells were depleted using magnetic separation, yielding 95%-97% pure populations of T cells. Cells were cultured in RPMI 1640 medium supplemented with 10% FCS, 250 g/mL gentamicin, 100 U/mL penicillin, 4mM glutamine, and 50M 2-mercaptoethanol (complete medium). Unless indicated otherwise, T cells were stimulated with 5 g/mL plate-bound ␣-CD3 (145-2C11; BD Biosciences PharMingen) and 3 g/mL ␣-CD28 (37.51; BD Biosciences PharMingen), or PMA (20 ng/mL) and ionomycin (1 g/mL). To induce Th polarization, T cells were cultured for 4 to 6 days in the presence of plate-bound ␣-CD3 and ␣-CD28 in medium supplemented with IL-12 (2 ng/mL) and anti-IL-4 (10 g/mL) for Th1 polarization, with anti-IL-12 (10 g/mL) and IL-4 (10 ng/mL) for Th2 polarization, and with anti-IL-4 (10 g/mL), IL-6 (30 ng/mL), and TGF-␤ (10 ng/mL) for Th17 differentiation.
Proliferation assay
The 96-well flat-bottom plates were coated with ␣-CD28 and various amounts of ␣-CD3. Cells were pulsed with 1 Ci [ 3 H]thymidine 14 hours before harvesting, and [ 3 H]thymidine uptake was determined with a Wallac 1450 MicroBeta Liquid Scintillation Counter.
Immunoblotting and kinase assays
Protein extracts were prepared from equivalent numbers of cells and protein concentrations measured using Bio-Rad protein assay and equalized. Lysates were separated by SDS-PAGE, transferred to nitrocellulose membranes (Invitrogen), and immunoblotted with the indicated antibodies. For kinase assays, p38␣ or p38␤ was immunoprecipitated from cell lysates using isoform-specific antibodies and Protein G-Sepharose 4B Fast Flow Beads (Sigma-Aldrich). Beads were washed twice with lysis buffer (PBS with 0.5% Triton X-100) and once in kinase buffer (25mM Tris, 5mM ␤-glycerophosphate, 1mM Na 3 VO 4 , 1mM NaF, and 10mM MgCl 2 ) and incubated for 30 minutes at 30°C in 30 L with 1 g of glutathione S-transferase-ATF-2 (Cell Signaling) and 100M adenosine triphosphate, followed by immunoblotting with anti-phospho-ATF-2.
Enzyme-linked immunosorbent assay
Supernatants from T cells stimulated in vitro were analyzed for IFN-␥ with regents purchased from BD Biosciences, using mouse recombinant IFN-␥ obtained from National Institute of Allergy and Infectious Diseases Reference Reagent Repository as a standard. Serum IFN-␣ was assayed with an enzyme-linked immunosorbent assay kit obtained from PBL Biomedical Laboratories. For detection of dsDNA and histone antibodies, serially diluted samples were incubated in 96-well plates coated with poly-L-lysine for 1 hour in 37°C and dsDNA (10 g/mL) or histone (10 g/mL) overnight at 4°C. The presence of anti-dsDNA or antihistone antibodies was detected using peroxidase-labeled goat anti-mouse IgG(H ϩ L) antibody (Kirkegaard & Perry Laboratories) and TMB Substrate Reagents (BD Biosciences). The antibody titer was calculated according to the method of Frey et al. 25 
Flow cytometry
To detect intracellular cytokines, cells were treated with monensin (3M) 3 to 4 hours before harvesting, stained with anti-CD4 antibody, fixed using BD Cytofix/Cytoperm kit (BD Biosciences), and stained in the presence of 2.4G2 antibody to block FcR binding. For detection of P-p38, cells were stimulated for 30 minutes with plate-bound ␣-CD3 (10 g/mL) and ␣-CD28 (3 g/mL), fixed with 4% paraformaldehyde, and permeabilized in methanol on ice. Flow cytometry was conducted with a FACSCalibur using CellQuest Pro 5.2.1 software (BD Biosciences). Data were analyzed with FlowJo 9.2 software (TreeStar).
Induction of EAE and CIA
EAE was induced by subcutaneous injection of MOG peptide emulsified in Complete Freund Adjuvant (CFA; Hooke Laboratories) at 2 sites on the lower back and intraperitoneal injection of 100 L of pertussis toxin, with a second intraperitoneal injection of pertussis toxin the next day. The severity of EAE was scored as follows: 0, no obvious changes; 1, limp tail; 2, limp tail and weakness of hind legs; 3, limp tail and complete paralysis of hind legs; 4, limp tail, complete hind leg and partial front leg paralysis; and 5, complete paralysis. For induction of CIA, 10-week-old H-2 r Gadd45␣ Ϫ/Ϫ and p38␣␤ Y323F mice were injected with 100 g bovine type II collagen emulsified in CFA at the base of the tail, and 21 days later boosted with 100 g bovine type II collagen emulsified in Incomplete Freund Adjuvant. Each paw was scored as follows: 0, no evidence of erythema; 1, erythema and mild swelling confined to tarsals; 2, erythema and mild swelling extending from the ankle to midfoot; 3, swelling extending from the ankle to metatarsal joints; and 4, severe swelling/ankylosis of the whole foot.
Results
Generation of p38␤ Y323F mice
To assess the contribution of p38␤ to T-cell activation, we generated knockin mice in which p38␤ Tyr-323 was replaced with Phe (p38␤ Y323F ). A homologous recombinant targeting vector containing a neo-resistance cassette and the Y323F mutation was constructed. Introduction of the Y323F mutation caused the deletion of a BanII-specific restriction site, which was used to test for the presence of the mutation ( Figure 1A ). Embryonic stem cells [(129 ϫ C57BL/6)F 1 ] were transfected with the targeting vector, and recombinant embryonic stem clones were injected into C57BL/6 blastocysts. The presence of the p38␤ Y323F allele was determined by Southern blot using HindIII and XmnI restriction enzymes. This digestion yielded a sequence containing both parts of the construction vector and the endogenous p38␤ gene. The WT band detected by Southern blot was 8.6 kb, and the knockin band was 9.8 kb because of the presence of the neo-cassette ( Figure 1B) . Insertion of the Y323F mutation was confirmed by BanII digestion, which failed to cleave the p38␤ PCR product ( Figure 1C ). Homozygous p38␤ Y323F mice were viable, fertile, and of normal size and weight.
Quantitating relative contributions of p38␣ and p38␤ in TCR-stimulated T cells
T cells from p38␤ Y323F mice were examined for induction of p38␤ activity in response to TCR signaling using an in vitro kinase assay. Stimulation with anti-CD3/anti-CD28 resulted in increased p38␤ activity in WT but not p38␤ Y323F T cells ( Figure 2A ). This defect was specific to the alternative activation pathway because p38␤ activity was induced to similar levels in T cells of both genotypes by PMA, which activates the classic MAPK cascade. TCR-induced p38␣ activity was normal (data not shown). These results are the reciprocal of those obtained with p38␣ Y323F T cells, in which p38␤ but not p38␣ was activated via the TCR. 8 Activated p38 can be quantitated by flow cytometry using antibodies that detect p38 Thr180 phosphorylation. It has not been possible to determine the relative contributions of p38␣ versus p38␤ in cells because antibodies that detect the phosphorylated and activated species cannot distinguish between these isoforms. However, because the Y323F substitution prevents activation loop phosphorylation of only the mutated isoform, the p38␣ and p38␤ knockin mice allowed us to quantitate p38 isoform activation in vivo. T cells from WT, p38␣ Y323F , p38␤ Y323F , and p38␣␤ Y323F mice were stimulated with plate-bound anti-CD3 and anti-CD28 and stained with phospho-specific p38 antibodies. A representative experiment is shown in Figure 2B . Activation-induced total P-p38 was reduced in T cells from both knockin mice, but clearly to a greater extent in p38␣ Y323F than p38␤ Y323F T cells. Little, if any, P-p38 was detected in double knockin T cells, demonstrating that the alternative pathway accounts for the vast majority of p38 activation subsequent to stimulation via the TCR. Results from 5 independent experiments revealed that the relative contribution of p38␣ to total p38 activity after TCR stimulation is ϳ 70%, with p38␤ accounting for the remainder ( Figure 2C ). It is noteworthy that the contribution of p38␤ to total T-cell p38 activity is substantial and higher than one would expect from the relative levels of p38 isoform mRNA in CD4 T cells, where it was judged that p38␤ was present at 2%-5% of p38␣ levels. 26 
Alternative p38 activation is a positive regulator of T-cell proliferation
Alternative activation of both p38 isoforms is abrogated in p38␣␤ Y323F mice, which allowed us to ask what biologic functions are downstream of TCR-activated p38. Previous studies of p38␣ Y323F T cells showed a modest delay in the onset and extent of proliferation. 8 Given that p38␤ makes a substantial contribution to total T-cell p38 activity ( Figure 2C ), we asked whether p38␤ could partially compensate for the lack of p38␣. WT, p38␣ Y323F , p38␤ Y323F , and p38␣␤ Y323F T cells were stimulated with various concentrations of anti-CD3 plus a constant amount of anti-CD28 and proliferation measured by [ 3 H]thymidine incorporation after 48 hours. Whereas the p38␣ Y323F and p38␤ Y323F T cells proliferated slightly less well than WT T cells, T cells in which neither p38 isoform could be activated proliferated much less well, having a 3-to 5-fold shift in the dose-response curve to the right compared with WT T cells ( Figure 3A ). Previous results with p38␣ Y323F T cells found no differences in induction of IL-2 expression compared with WT cells, 8 unpublished observations, 2010). Therefore, p38␣ and p38␤ play partially redundant and positive roles in T-cell proliferation.
Alternative p38 activation, cytokine production, and Th skewing
Production of the proinflammatory cytokines IFN-␥ and TNF-␣ in TCR-stimulated unskewed primary p38␣ Y323F T cells was reduced to a small degree. 8 Intracellular staining of IFN-␥ and TNF-␣ in TCR-activated p38␤ Y323F T cells found that production of these cytokines was also reduced, but to a lesser extent than in p38␣ Y323F cells, and that the p38␣␤ Y323F double-knockin T cells had reductions only slightly greater than p38␣ Y323F T cells (supplemental Figure 1 , available on the Blood Web site; see the Supplemental Materials link at the top of the online article). Thus, unlike T-cell proliferation, the contribution of p38 activity to the production of IFN-␥ and TNF-␣ by unskewed cells is largely mediated by p38␣. Previous results with T cells from p38␣ Y323F mice found normal Th1 skewing in vitro, as judged by IFN-␥ production in response to stimulation with PMA and ionomycin (P ϩ I). 8 The question of what role p38 might have in Th skewing was revisited with mice completely lacking the alternative pathway by stimulating purified WT and p38␣␤ Y323F T cells with plate-bound anti-CD3/anti-CD28 antibodies in the presence of Th1-, Th2-, or Th17-skewing cytokines. After 6 days, the cells were washed, rested overnight, and restimulated with either with plate-bound anti-CD3 or P ϩ I for 6 hours and stained for intracellular cytokines ( Figure 3B-G) . WT cells cultured under Th1-skewing conditions had ϳ 48% and 59% IFN-␥-positive cells after TCR and P ϩ I stimulation, respectively ( Figure 3B-C Figure 3B ). The finding that the IFN-␥ response to P ϩ I, a stimulus that bypasses the TCR and activates the classic MAPK cascade, is reduced was unexpected given the previous results with the p38␣ Y323F knockin mice in which the response was normal. 8 Given that there was no effect on Th1 skewing in p38␤ Y323F T cells (data not shown), these results indicate that p38␣ and p38␤ have an important and redundant role in this process. The lack of alternatively activated p38 had a very different effect on Th2 skewing. The number of Th2-skewed cells producing IL-4 was similar between WT and p38␣␤ Y323F cells ( Figure 3D,F) . There was a small but reproducible increase in the number of p38␣␤ Y323F Th2 cells that produced IL-10 compared with WT cells. Th17 differentiation was induced in vitro with TGF-␤ and IL-6 for 6 days, and on restimulation with anti-CD3 or P ϩ I both WT and p38␣␤ Y323F cells produced IL-17 but not IFN-␥. However, the percentage of IL-17-producing cells was decreased in p38␣␤ Y323F Th17-skewed cells by 20%-40% ( Figure 3E ,G). Th1 and Th17 skewing was impaired in the absence of TCR-induced p38 activation.
T helper cell differentiation is driven by transcription factors T-bet (toward a Th1 phenotype) and GATA-3 (toward Th2). 27 Because we observed decreased production of Th1 cytokines by skewed p38␣␤ Y323F effectors, we investigated the levels of T-bet and GATA-3 achieved in these cells. WT and p38␣␤ Y323F cells were cultured under Th1-or Th2-skewing conditions, and on days 1 through 4 the cells were harvested and either lysed and assayed for T-bet expression by Western blot or fixed and analyzed for GATA-3 expression by flow cytometry. WT T cells expressed high levels of T-bet on day 1 and day 2; and although declining thereafter, the protein was still easily detectable on day 4 ( Figure 4A ). p38␣␤ Y323F T cells also expressed T-bet on day 1, but the level rapidly declined by day 2, and the signal was low to undetectable by day 4. On the other hand, p38␣␤ Y323F cells cultured under Th2 conditions expressed slightly more GATA-3 than WT cells at later time points (Figure 4B-C 
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T-cell hyperproliferation and spontaneous autoimmunity in Gadd45␣ ؊/؊ mice is ablated by introducing p38␣ Y323F
Unchecked production of inflammatory cytokines is implicated in development of chronic autoimmune conditions, such as multiple sclerosis and rheumatoid arthritis. 18, 19, 28, 29 In resting T cells, Gadd45␣ inhibits the spontaneous activity of Tyr-323-phosphorylated p38, and Gadd45␣-deficient mice have constitutively active T-cell p38 and, as they age, develop a systemic autoimmune disease characterized by high titers of anti-dsDNA and antihistone antibodies, glomerulonephritis, and proteinuria. 9, 10 We had originally hypothesized that the T-cell hyperproliferation and autoimmunity in Gadd45␣-deficient mice were the result of spontaneous activation of p38, 10 but at that time there was no means to directly test this. This can be tested now, however, by crossing p38␣ Y323F with Gadd45␣ Ϫ/Ϫ mice to generate Gadd45␣ Ϫ/Ϫ (GKO)/p38␣ Y323F animals. Spontaneous p38␣ activity was reduced in T cells from GKO/p38␣ Y323F mice compared with Gadd45␣-deficient animals and was not up-regulated in response to TCR signaling (supplemental Figure 2) . As previously shown, 10 Gadd45␣-deficient T cells proliferated better than WT T cells in response to TCR-mediated stimulation. TCR-mediated proliferation was reduced by introduction of p38␣ Y323F mutation to that of, or even a bit less than, WT levels ( Figure 5A ). The proliferation of GKO/ p38␣ Y323F T cells was still greater than that of p38␣ Y323F T cells, consistent with a role for the residual alternatively activated p38␤ in these cells. This was indeed the case because GKO/p38␣␤ Y323F T cells proliferated less well than WT cells ( Figure 5B ). In this case, the proliferation of GKO/p38␣␤ Y323F T cells was reduced to the level of p38␣␤ Y323F T cells, confirming that the hyperproliferation of Gadd45␣-deficient T cells is the result of their spontaneously elevated p38 activity. Gadd45␣-deficient mice develop mild systemic autoimmunity, especially female animals, and begin to die at approximately 16 months of age. 9 The animals in that study were littermates that were intercrossed from the (129 ϫ C57BL/6)F 1 stage. We subsequently backcrossed those animals to C57BL/6 for 8 generations and found that they no longer died prematurely, and that although still present, signs of autoimmunity were less pronounced. This is consistent with other reports that the 129 background is more prone to autoimmunity than C57BL/6. 30 Evidence of autoimmunity was quantitated by determining the titers of dsDNA and histone antibodies in the sera of aging GKO, p38␣ Y323F , and GKO/p38␣ Y323F female mice (n ϭ 15 per group). GKO mice had elevated antibodies against histone and dsDNA compared with WT by 6 (antihistone) or 9 (anti-dsDNA) months of age ( Figure 5C ). Notably, introduction of p38␣ Y323F resulted in titers that were similar to WT levels. Elevated levels of autoantibodies can trigger TLR-7 and TLR-9 signaling, leading to increased production of IFN-␣ by plasmacytoid dendritic cells. 31 In agreement, we found increased levels of circulating IFN-␣ in GKO mice that were reduced to normal levels by the introduction of p38␣ Y323F ( Figure 5D ). Autoantibodies can lead to glomerulonephritis, which was detected in the GKO mice on the 129 ϫ C57BL/ 6 background. 9 Consistent with the moderating influence of the C57BL/6 background on autoimmunity, the B6 GKO mice had no histologic evidence of glomerulonephritis (data not shown; L.J. and J.D.A., unpublished observations, 2010), but they did have elevated levels of protein in the urine ( Figure 5E ). This too was reversed by introduction of p38␣ Y323F . Hence, introduction of the p38␣ Y323F mutation into mice lacking Gadd45␣ abolished signs of autoimmunity in aging mice, indicating that activation 
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of alternatively activated p38␣ in T cells was an essential etiologic factor in the development of disease.
Disruption of alternative T-cell p38 activation reduces the severity of autoimmunity and inflammation in CIA and EAE
Rheumatoid arthritis is an inflammatory autoimmune disorder characterized by high levels of TNF-␣, IL-1, and other inflammatory cytokines in rheumatoid joints. 18 The importance of p38 in the production of TNF-␣ 23,32,33 prompted us to test the role of TCR-mediated p38 activation in CIA, a mouse model of rheumatoid arthritis. WT and p38␣␤ Y323F C57BL/6 mice were backcrossed onto B10.RIII to obtain animals homozygous for H-2 r , the MHC haplotype that provides susceptibility to CIA. 34 Ten-week-old mice were immunized with type II collagen in CFA at the base of the tail and boosted with type II collagen in Incomplete Freund Adjuvant 21 days later. WT animals showed the first signs of disease one day after the second injection, whereas no signs were detected in p38␣␤ Y323F animals until 6 days had passed ( Figure 6B) . Moreover, arthritis progressed in the WT animals to a much greater degree of severity than in p38␣␤ Y323F mice. This was exemplified by that fact that most WT animals developed ankylosis and loss of function involving 2 or more limbs, compared with only mild swelling (score of 2ϩ) and rare ankylosis in p38␣␤ Y323F mice ( Figure 6A,C) .
To ask whether a role for alternatively activated p38 might be extended to other examples of autoimmunity, we characterized the development and progression of EAE, a mouse model of the inflammatory autoimmune disease multiple sclerosis. Elevated phosphorylated (active) p38 activity has been found in T cells in EAE lesions, 21 and recent findings suggest that infiltration of the central nervous system with IL-17-and IFN-␥-producing T cells mediates inflammation leading to clinical signs of EAE. 19 EAE was induced in WT and p38␣␤ Y323F mice by immunization with MOG (Figure 7 ). The onset of EAE was delayed in p38␣␤ Y323F mice compared with WT animals. The clinical severity was lower throughout the course of the experiment, and the p38␣␤ Y323F animals recovered much earlier than their WT counterparts. Taken together, these results demonstrate that T-cell p38 activation downstream of the TCR contributes to autoimmune inflammatory disease.
Discussion
The physiologic function of the T cell-specific alternative p38 activation pathway, as opposed to the MAPK-dependent pathway, is an open 
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Uncontrolled production of inflammatory cytokines is a major contributing factor in the chronic inflammation typical of autoimmune diseases. 38 Although there is a great deal of information about the connection between p38 and inflammation, relatively little is known about the specific role of T-cell p38, or in particular about the role of p38 activated in response to TCR signaling, issues that could be addressed with the p38 knockin mice. Several models of autoimmunity and inflammation were examined. Gadd45␣-deficient elevated alternatively activated T-cell p38, T-cell hyperproliferation and develop autoimmunity. 9, 10 Introduction of p38␣ Y323F into Gadd45␣ knockout mice (GKO/ p38␣ Y323F ) not only prevented T-cell hyperproliferation, it reduced antihistone and anti-dsDNA antibodies and proteinuria to WT levels, despite the presence of WT p38␤. Therefore, T-cell p38␣ activated by the alternative pathway is necessary for the development of autoimmunity in Gadd45␣ knockout mice.
CIA and EAE are widely used murine models for rheumatoid arthritis and multiple sclerosis, respectively. In both cases, lack of TCR-signaled p38 activation resulted in substantial reductions in the severity of disease. It is noteworthy that Gadd45␣ mice, in which T-cell p38 is constitutively active, had more severe CIA and EAE than WT counterparts (L.J. and J.D.A., unpublished observations, 2010). Characterization of T-cell responses to activation suggests several mechanisms that may underlie the resistance of p38␣␤ Y323F mice. First, these T cells do not proliferate as well as WT cells in response to TCR-mediated stimulation, so the T-cell response to the disease-initiating antigens would be blunted. Second, IFN-␥ and IL-17 production was decreased in p38␣␤ Y323F and increased in Gadd45␣KO, Th-skewed cells. These cytokines are implicated in the development of EAE 20 and multiple sclerosis, 29 and suppression of Th1/Th17 cytokine production is one of the therapeutic approaches being applied to multiple sclerosis and rheumatoid arthritis. 38, 39 The positive role of p38 in the production of inflammatory cytokines has been a rationale for the use of p38 inhibitors to alleviate chronic inflammation. However, despite some positive results, 40 global inhibition of p38 activity is associated with side effects, such as infection and gastrointestinal disturbances, [41] [42] [43] possibly because of the ubiquitous expression of p38 and its large variety of functions. 44, 45 Our data provide direct genetic evidence that T-cell p38 activated in response to TCR signaling contributes to inflammatory autoimmune responses. Because the TCR activates p38 by a mechanism distinct from other receptors and stresses, these results raise the possibility that specific interference with the alternative p38 activation pathway might be beneficial in inflammatory autoimmune conditions. Furthermore, the preservation of normal p38 activation in response to non-TCR-mediated stimuli and in non-T cells might mitigate unwanted side effects. Gadd45␣, which inhibits p38 activated by the alternative pathway but not the MAPK cascade, 10 provides evidence that pathway-specific inhibition is possible.
